Michael I McCabe

Head of Strategy purchases 120,000 STEP shares for $5,022,072.49; holdings jump 38.3% amid stock decline from 52-week highs.

Michael I McCabe, Head of Strategy at StepStone Group Inc., executed 2 separate purchases on 2026-06-11 totaling 120,000 shares for $5,022,072.49 at a blended average price of $41.85—a material 38.3% increase to his shareholding from 313,178 to 433,178 shares. This acquisition occurs while the stock trades at $42.52, down 45.4% from its 52-week high of $77.80 and down 24.3% over the past 30 days, signaling a substantial accumulation during a period of significant stock weakness. StepStone remains unprofitable with net income of $-123,451,000.00 in its most recent full fiscal year, though it reported 69.7% annual revenue growth (to $586,511,000.00 in latest quarter), presenting a company in scale-up mode with near-term losses. McCabe's same-ticker trading history shows 5 prior transactions at STEP, predominantly sales (3 of which on the same date in December 2025), with mixed timing outcomes; this buy-side entry into depressed valuation warrants attention to whether fundamentals justify his conviction or whether execution constraints persist.

Head of Strategy McCabe sold 192,052 shares (61.1% of holdings) for $12.7M at $66.18 blended average

McCabe Michael I executed 3 separate sales totaling 192,052 shares for $12,709,728.66, reducing his holdings from 314,261 to 122,209 shares (a -61.1% reduction of pre-transaction holdings). The blended average price of $66.18 sits just above the current price of $64.40 and near the 52-week high range. His prior 4 sales at StepStone showed no well-timed outcomes (0 of 4 prior sells achieved negative 90-day returns), and at the cross-ticker level his timing rate stands at 0.00%, suggesting his prior exit decisions did not precede stock declines. StepStone faces a material headwind: the company reported a net loss of $-366,142,000.00 on revenue of $454,225,000.00 in its latest quarter and was unprofitable over its most recent full fiscal year, despite delivering +65.1% annual revenue growth. The substantial reduction in a senior executive's stake merits investor attention given the company's current profitability challenges.

Head of Strategy Michael McCabe sold 67.7K shares of STEP at $56.54; stock down -22.5% from 52-week high, company unprofitable (-$192.0M net income).

McCabe, Head of Strategy, sold 67,718 shares for $3,828,775.72, reducing his holdings by 13.8% from 491,582 to 423,864 shares. The transaction occurred at $56.54 per share, while the stock now trades at $53.73, having declined 22.5% from its 52-week high of $69.32 and 9.8% over the past 30 days. Notably, McCabe executed three prior sales at STEP on 2025-05-28 (outcomes not yet measurable), and his cross-ticker track record shows 3 prior sells with no successful timing pattern at the 90-day measurement. The fundamental backdrop adds context: the company generated $339.0M in quarterly revenue but reported a net loss of $192.0M (unprofitable over the last full fiscal year), despite posting 65.1% annual revenue growth. The combination of substantial executive share reduction, negative recent price momentum, and ongoing unprofitability warrants investor attention to whether operational challenges or valuation concerns are driving the selling pattern.

Head of Strategy McCabe sold 251,118 shares (56.1% of holdings) for $15,046,017.02 at $59.92 avg; company unprofitable

Michael I McCabe, Head of Strategy at StepStone Group, executed three separate sales totaling 251,118 shares for $15,046,017.02 at a blended average price of $59.92 on May 28, 2025, reducing his holdings from 447,541 shares to 196,423 shares (a 56.1% reduction). This is a material liquidation of his equity stake. StepStone reported a latest-quarter revenue of $339,023,000.00 with a net loss of $192,015,000.00, and the company remains unprofitable on a full-year basis despite 65.1% annual revenue growth. The sale occurred near the 52-week high of $69.32 (current price $57.85, -16.6% from that high), though the stock has gained 15.7% over the past 30 days. The size and proportion of this reduction warrant investor attention given the company's negative earnings profile and the timing relative to recent price momentum.